Floatz logo

Therapeutic Asset Ratings

6,308 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Atamparib
Non-Small Cell Squamous Lung Carcinoma
Ribon Therapeutics, Inc.P1/2CC (47)
Atamparib
Lung Adenocarcinoma
Nerviano Medical Sciences (Shanghai) Ltd.P1/2CC (47)
Atezolizumab
Bile Duct Cancer
University of FloridaP1/2CC (47)
Atezolizumab
Fibrolamellar Hepatocellular Carcinoma
St. Jude Children's Research HospitalP1/2CC (47)
Atezolizumab
Large Cell Neuroendocrine Carcinoma
Phanes TherapeuticsP1/2CC (47)
Atezolizumab
Prostate Neuroendocrine Neoplasm
Phanes TherapeuticsP1/2CC (47)
Atezolizumab
Vulva Cancer
University of FloridaP1/2CC (47)
Atrovastain
Hodgkins Lymphoma
Assiut UniversityP1/2CC (47)
Autologous Bcma/Cd19 Dual-Target Car-T Module
B-Cell Acute Lymphoblastic Leukemia
Beijing BiotechP1/2CC (47)
Autologous Bcma/Cd19 Dual-Target Car-T Module
B-Cell Non-Hodgkin Lymphoma
Beijing BiotechP1/2CC (47)
Autologous Bcma/Cd19 Dual-Target Car-T Module
Plasma Cell Myeloma
Beijing BiotechP1/2CC (47)
Autologous Bcma/Cd38 Dual-Target Car-T Module
B-Cell Acute Lymphoblastic Leukemia
Beijing BiotechP1/2CC (47)
Autologous Bcma/Cd38 Dual-Target Car-T Module
B-Cell Non-Hodgkin Lymphoma
Beijing BiotechP1/2CC (47)
Autologous Bcma/Cd38 Dual-Target Car-T Module
Plasma Cell Myeloma
Beijing BiotechP1/2CC (47)
Autologous Bcma/Gprc5D Dual-Target Car-T
B-Cell Acute Lymphoblastic Leukemia
Beijing BiotechP1/2CC (47)
Autologous Bcma/Gprc5D Dual-Target Car-T
B-Cell Non-Hodgkin Lymphoma
Beijing BiotechP1/2CC (47)
Autologous Bcma/Gprc5D Dual-Target Car-T
Plasma Cell Myeloma
Beijing BiotechP1/2CC (47)
Autologous Cd19/Cd20 Dual-Target Car-T Module
B-Cell Acute Lymphoblastic Leukemia
Beijing BiotechP1/2CC (47)
Autologous Cd19/Cd20 Dual-Target Car-T Module
B-Cell Non-Hodgkin Lymphoma
Beijing BiotechP1/2CC (47)
Autologous Cd19/Cd20 Dual-Target Car-T Module
Plasma Cell Myeloma
Beijing BiotechP1/2CC (47)
Autologous Cd19/Cd22 Dual-Target Car-T Module
B-Cell Acute Lymphoblastic Leukemia
Beijing BiotechP1/2CC (47)
Autologous Cd19/Cd22 Dual-Target Car-T Module
B-Cell Non-Hodgkin Lymphoma
Beijing BiotechP1/2CC (47)
Autologous Cd19/Cd22 Dual-Target Car-T Module
Plasma Cell Myeloma
Beijing BiotechP1/2CC (47)
Autologous Cd19-Star-T Cell
B-Cell Non-Hodgkin Lymphoma
Chinese PLA General HospitalP1/2CC (47)
Autologous Cd33/Cd123 Dual-Target Car-T Module
B-Cell Acute Lymphoblastic Leukemia
Beijing BiotechP1/2CC (47)
Showing 2151 to 2175 of 6,308 assets
PreviousPage 87 of 253Next